Status:
COMPLETED
Concordance Between Monitoring Systems for Organ/Space Surgical Site Infections in Rectal Surgery
Lead Sponsor:
Hospital de Granollers
Collaborating Sponsors:
Institut d'Investigació Biomèdica de Bellvitge
Institut Català d'Oncologia
Conditions:
Rectal Cancer
Organ-Space Surgical Site Infection
Eligibility:
All Genders
18+ years
Brief Summary
The Catalan Cancer Plan (CCP) undertakes periodic audits of cancer treatment outcomes, including organ/space surgical site infections (O/S-SSI) rates, while the Catalan Healthcare-associated Infection...
Detailed Description
The healthcare system in Catalonia (Spain) monitors and reports SSI in cancer patients through two principal mechanisms. First of all, the Catalan Cancer Plan (CCP) is a Health Department structure th...
Eligibility Criteria
Inclusion
- Patients \> 18 years old
- Eligible patients with tumour ≤ 13 cm from anal verge, as measured by Magnetic Resonance Imaging
- Primary adenocarcinoma
- Oncological resection with curative intent
- Cancer stages: I-II-III
Exclusion
- Transanal local resection
- Emergency colorectal surgeries
- Presence of metastases found in the diagnostic process or during the surgical procedure
- Recurrence of the disease treated before the study period
- Non-resectable tumour or palliative surgery
- Patients operated in private centres
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
11367 Patients enrolled
Trial Details
Trial ID
NCT06104579
Start Date
January 1 2011
End Date
July 30 2023
Last Update
May 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Català d'Oncologia
L'Hospitalet de Llobregat, Barcelona, Spain, 08908